For whatever reason, the grownups seem to get all the attention when talk turns to AI in healthcare. All the kiddos get to do is look on and listen in. Now comes a worthy little effort to balance the seesaw.

Updated reporting from HHS shows UnitedHealth Group's estimate that roughly one-third of people in the U.S. would be affected was correct. 

Pfizer's Abrysvo vaccine can now be prescribed to all adults 18 and older at high risk for severe RSV complications, including pregnant women. 

Thousands of patients have filed a class-action lawsuit against the insurer for issuing directories of providers who were out-of-network and did not take BCBS health plans. 

It’s going to take a multinational effort for the global AI community—such as it is—to avoid the emergence of a “fragmented AI landscape.” 

The popular annual conference that brings in diverse healthcare professionals from all over the world is wrapping up. Here are some of the big announcements.

While production is relatively unchanged compared to the previous year, compensation is up significantly for cardiovascular surgeons in the United States. 

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.